Close
Novotech
Jabsco PureFlo 21 Single Use

Australia Approves Covid Vaccine Booster Shots For 18 And Above

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition

Neurocrine Biosciences is close to securing a more than...

Biogen to Acquire Apellis for $5.6 Billion in Major Deal

Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc....

Trump Announces 100% US Pharma Tariffs for Patented Drugs

The US pharma tariffs policy has been formalised through...
- Advertisement -

Australia on Wednesday authorised booster shots of Covid-19 vaccines for over-18s, with the third dose expected to be offered to the entire population from next month.

The Therapeutic Goods Administration regulatory authority said it had granted provisional approval for one dose of the Pfizer-BioNTech vaccine to be given as a booster shot to adults.

“The provisional approval means that individuals aged 18 years and older may receive a booster (third dose), at least six months after the completion of a Covid-19 vaccine primary series,” the agency said.

Health Minister Greg Hunt said a population-wide booster program would begin no later than November 8, subject to approval from the nation’s immunisation advisory body. “We will commence with aged care and disability as a priority,” he told reporters in Canberra.

Hunt said the “universal booster” would be available to anyone who had received two doses of either the Pfizer-BioNTech, Oxford/AstraZeneca or Moderna vaccine. Australia has so far double-dosed 74 percent of its population aged over 16, with 87 percent having received a single jab.

Booster shots had already been made available to severely immunocompromised people earlier in October. The government said it expected Moderna would also apply to Australia’s medical regulator for booster shot approval.

Latest stories

Related stories

Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition

Neurocrine Biosciences is close to securing a more than...

Biogen to Acquire Apellis for $5.6 Billion in Major Deal

Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc....

Trump Announces 100% US Pharma Tariffs for Patented Drugs

The US pharma tariffs policy has been formalised through...

Biomaterials and Local Drug Delivery in Implant Surgery

Advances in biomaterials and localized drug delivery systems are...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »